about
Obesity alters gut microbial ecologyMechanisms underlying the resistance to diet-induced obesity in germ-free miceAssessing the human gut microbiota in metabolic diseasesAge-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in MiceFarnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cellsHost-bacterial mutualism in the human intestineMicrobial regulation of GLP-1 and L-cell biologyThe gut microbiota as an environmental factor that regulates fat storageFXR is a molecular target for the effects of vertical sleeve gastrectomyThe gut microbiota--masters of host development and physiologyFunctional interactions between the gut microbiota and host metabolismHuman oral, gut, and plaque microbiota in patients with atherosclerosis.Expression of the blood-group-related glycosyltransferase B4galnt2 influences the intestinal microbiota in miceComparative analysis of human gut microbiota by barcoded pyrosequencingRegulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota.Coordinated regulation of the metabolome and lipidome at the host-microbial interfaceOral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88.The endocannabinoid system links gut microbiota to adipogenesisMicrobial-induced meprin β cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus.Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesityAge-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibilitySymptomatic atherosclerosis is associated with an altered gut metagenomeGut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.Gut metagenome in European women with normal, impaired and diabetic glucose control.Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severityLactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications.Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome.Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling.The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic miceIntestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancersHelicobacter pylori infection induces interleukin-8 receptor expression in the human gastric epithelium.The composition of the gut microbiota shapes the colon mucus barrier.Toll-like receptor 4-mediated signaling by epithelial surfaces: necessity or threat?The gut microbiota engages different signaling pathways to induce Duox2 expression in the ileum and colon epithelium.Microbial modulation of insulin sensitivity.Site-specific programming of the host epithelial transcriptome by the gut microbiotaInsights into the role of the microbiome in obesity and type 2 diabetes.
P50
Q24531503-25D94CD9-0B00-4197-9FCE-4F12B47B7E93Q24676006-1DEC359A-955C-4570-91B4-0D846D7E3C0AQ26860785-82A1488F-8A92-45B6-9871-B4764DFA7E9DQ27313870-5A961DAE-947B-4491-9437-62A610995DABQ27324038-2C1D925E-F0C1-462B-9701-1901F7588587Q27861037-D9FBD5F8-D169-41D3-9559-E6649A40D70BQ28072517-C824AD36-2AB5-4EEF-BC29-CD28A3C9A091Q28131676-CA4D21F4-F33E-416C-96A4-37FD44BEE3A3Q28236848-EF83C5A1-016F-4A7C-A10B-A1AF2030F0B6Q28286102-606380EB-D69A-4700-AB9D-BAC0ABC9CF45Q29616815-580F0CD4-484E-44D0-AD5C-14189212CC59Q30499024-C7FC2E1D-718C-431F-94E8-A6177C2BE67AQ30517268-2B72F6D9-18C4-408E-978C-2A55920769FDQ33356063-B693F86D-E1E6-4FE4-8739-C51DEF33F16BQ33464953-4EC5777C-B745-42E9-9A2E-8B439F4A4200Q33664070-1AA0676E-CE56-400C-B242-9DE65EA116BEQ33914924-7AB2E788-7802-4DDC-BB98-AC482EC8A754Q34029519-E684387A-EEBC-4323-B31F-FA87175EC65BQ34078880-51B97E81-27F9-47EE-8D20-E8A940BC2AD7Q34120082-FDCEF6F2-48C5-4C48-BB19-AF06D233E592Q34175068-992092F2-99E8-4DA3-B762-EA9CE2F5F7F5Q34263052-81F73A66-6A44-4211-BC1E-ACF296B00AE4Q34315625-6625687D-7CC7-47F5-A1D2-1F06B2069886Q34326973-44B3885E-13E7-400D-8F48-B96BBE68FFA9Q34347521-66A23937-CC72-43E5-A5D2-9A6BF846AEF0Q34409186-7B09CCE8-492C-4914-9051-E7C48F67246CQ34442261-88811D8A-DD77-4120-AD63-5350A99F6D72Q34480156-0B2261B5-A9A1-4110-8FEC-067D0FD6762FQ34488351-2D70882B-3141-4567-B00B-8E34D5E1FFE3Q34491604-EADB5708-4681-4528-A1EA-83F70CE0E964Q34497283-BE1BC453-E352-471D-9D34-6219AFCD7465Q34720051-9D5DF546-488E-49D5-8563-C05CAB419145Q34945291-353E13FB-19CE-432F-B40F-216F35B61BDEQ35013055-B76561A8-AC12-4CF8-ABD1-F042761D97DCQ35084532-268AE0A4-FC14-4DDC-8E03-62732B91D371Q35206850-D91322B7-BB5D-4D81-B22D-D7C25C7DA3F8Q35232650-39B642A2-9668-4025-89D7-20168AB19C96Q35235971-04F4674C-3EC0-41AD-9EC1-02C4B768A17DQ35500118-AABA021D-5E85-46D2-9B9B-BB36BB954713Q35533602-B7DB7CFC-64FA-4A33-A5F5-9ABACB0163F4
P50
description
Zweeds onderzoeker
@nl
hulumtues
@sq
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Fredrik Bäckhed
@ast
Fredrik Bäckhed
@en
Fredrik Bäckhed
@es
Fredrik Bäckhed
@ga
Fredrik Bäckhed
@nl
Fredrik Bäckhed
@sl
Fredrik Bäckhed
@sq
type
label
Fredrik Bäckhed
@ast
Fredrik Bäckhed
@en
Fredrik Bäckhed
@es
Fredrik Bäckhed
@ga
Fredrik Bäckhed
@nl
Fredrik Bäckhed
@sl
Fredrik Bäckhed
@sq
prefLabel
Fredrik Bäckhed
@ast
Fredrik Bäckhed
@en
Fredrik Bäckhed
@es
Fredrik Bäckhed
@ga
Fredrik Bäckhed
@nl
Fredrik Bäckhed
@sl
Fredrik Bäckhed
@sq
P106
P1153
6602647502
P166
P21
P27
P31
P496
0000-0002-4871-8818
P569
1973-01-01T00:00:00Z